| 查看: 297 | 回复: 1 | ||
[求助]
微谱求助已有1人参与
|
| 13C NMR (126 MHz, CDCl3) δ26.92, 29.55, 30.61, 41.31, 42.80, 56.02, 56.15, 56.31, 71.83, 75.52, 91.39, 108.46, 112.01, 122.06, 124.54, 126.17, 129.50, 135.02, 147.20, 148.62, 152.17, 162.43, 194.81. |
» 猜你喜欢
投稿返修后收到这样的回复,还有希望吗
已经有7人回复
压汞仪和BET测气凝胶孔隙率
已经有4人回复
博士申请都是内定的吗?
已经有14人回复
博士申请
已经有3人回复
谈谈两天一夜的“延安行”
已经有13人回复
氨基封端PDMS和HDI反应快速固化
已经有11人回复
之前让一硕士生水了7个发明专利,现在这7个获批发明专利的维护费可从哪儿支出哈?
已经有11人回复
论文投稿求助
已经有4人回复
Applied Surface Science 这个期刊。有哪位虫友投过的能把word模板发给我参考一下嘛
已经有3人回复
投稿精细化工
已经有6人回复
seuseasoar
至尊木虫 (知名作家)
- 应助: 2238 (讲师)
- 金币: 47746.9
- 红花: 52
- 帖子: 6667
- 在线: 546.2小时
- 虫号: 2400995
- 注册: 2013-04-01
- 性别: MM
- 专业: 食品科学基础
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★
感谢参与,应助指数 +1
zhangrt9: 金币+8 2015-05-19 11:51:05
感谢参与,应助指数 +1
zhangrt9: 金币+8 2015-05-19 11:51:05
|
1 . (+)-Erysotrine C19H23O3N 相似度:56.5% Journal of Natural Products 1991 54 329-363 The Tetracyclic Erythrina Alkaloids Masouda E. Amer, Maurice Shamma, Alan J. Freyer Structure 13C NMR 碳谱模拟图 2 . Compound 12 C38H45NO12 相似度:56.5% Bioorganic & Medicinal Chemistry Letters 2003 13 1777-1781 Multidrug resistance reversal activity of key ningalin analogues Danielle R. Soenen, Inkyu Hwang, Michael P. Hedrick, Dale L. Boger Structure 13C NMR 碳谱模拟图 3 . (Z)-2-isobutyl-3-isopropyl-7,8-dimethoxy-1-(thiophen-3-ylmethylene)-2,3,4,5-tetrahydro-1H-benzo[d]azepine C24H33O2NS 相似度:56.5% European Journal of Organic Chemistry 2010 4868-4875 A Convenient Approach to 16-, 19-, and 22-Membered 2,2′-Bipyridine Thiacrown Ethers and Their Conformation Preferences Justyna Ławecka, Zbigniew Karczmarzyk, Ewa Wolińska, Danuta Branowska and Andrzej Rykowski Structure 13C NMR 碳谱模拟图 4 . erysothrine 相似度:56.5% Química Nova 2011 34 808-811 Anxiolytic-like effects of erythrinian alkaloids from erythrina suberosa Serrano, Maria Amélia Rodrigues; Batista, Andrea Nastri de Luca; Bolzani, Vanderlan da Silva; Santos, Luciana de ávila; Nogueira, Paulo José de Campos; Nunes-de-Souza, Ricardo Luiz; Latif, Abdul; Arfan, Mohammad Structure 13C NMR 碳谱模拟图 5 . 5-chloro-1-(1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)piperidin-4-yl)-3-ethyl-1H-benzo[d]imidazol-2(3H)-one 25H30ClN3O3 相似度:56.5% Medicinal Chemistry Research 2014 23 2133−2139 Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one derivatives as potential antimicrobial agents Vimal Patel, Nilay Bhatt, Pralav Bhatt, H. D. Joshi Structure 13C NMR 碳谱模拟图 6 . tetramethylfremontin 相似度:54.1% Journal of Natural Products 2006 69(1) 43-49 Isoflavonoids and Other Compounds from Psorothamnus arborescens with Antiprotozoal Activities Manar M. Salem, and Karl A. Werbovetz Structure 13C NMR 碳谱模拟图 7 . 4-O-methylokanin 4'-O-(6''-O-acetyl-β-D-glucopyranoside ) 相似度:54.1% Chemical & Pharmaceutical Bulletin 1992 40 689-691 New Acylated Glucosides of Chalocone from the Leaves of Bidens frondosa Hiroyuki KARIKOME,Kazunori OGAWA and Yutaka SASHIDA Structure 13C NMR 碳谱模拟图 8 . 6-O-Methyl-laudanosoline-1-O-glucoside C24H31NO9 相似度:54.1% Phytochemistry Letters 2009 2 77-80 Alkaloids inhibiting l-histidine decarboxylase from Sinomenium acutum Atsushi Kato, Megumi Yasui, Natsuki Yano, Yasuyoshi Kawata, Kuniaki Moriki, Isao Adachi, Jackie Hollinshead, Robert J. Nash Structure 13C NMR 碳谱模拟图 9 . 5-chloro-1-(1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)piperidin-4-yl)-3-(3-(dimethylamino)propyl)-1H-benzo[d]imidazol-2(3H)-one C28H37ClN4O3 相似度:54.1% Medicinal Chemistry Research 2014 23 2133−2139 Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one derivatives as potential antimicrobial agents Vimal Patel, Nilay Bhatt, Pralav Bhatt, H. D. Joshi Structure 13C NMR 碳谱模拟图 10 . 5-chloro-3-(4-chlorobenzyl)-1-(1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-yl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one C30H31Cl2N3O3 相似度:53.8% Medicinal Chemistry Research 2014 23 2133−2139 Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one derivatives as potential antimicrobial agents Vimal Patel, Nilay Bhatt, Pralav Bhatt, H. D. Joshi Structure 13C NMR 碳谱模拟图 |

2楼2015-05-19 11:45:55













回复此楼